https://european-biotechnology.net/wp-content/uploads/2026/01/Engitix-labs-london-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-08 12:28:132026-01-08 12:28:13Billionaire Mike Platt backs Engitix for the second time with a $25 million series A extension
https://european-biotechnology.net/wp-content/uploads/2026/01/Evotec4-1030x645-1.jpg6451030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-08 09:34:332026-01-08 09:34:33Evotec benefits from Dark Blue acquisition by Amgen
https://european-biotechnology.net/wp-content/uploads/2026/01/national-institute-of-allergy-and-infectious-diseases-n36qXSkND8g-unsplash-1030x743-1.jpg7431030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-07 18:28:432026-01-07 18:28:43Basilea strikes up to $48.5m antifungal deal with U.S. biotech Prokaryotics
https://european-biotechnology.net/wp-content/uploads/2026/01/maksym-harbar-okn8ZIjPMxI-unsplash-1030x773-1.jpg7731030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-07 12:52:162026-01-07 12:52:16Polish biotech JPP Biologics reports positive Phase I data for first-in-class biologic for immune diseases
https://european-biotechnology.net/wp-content/uploads/2026/01/EBSIN-Summer_2025_Techparks_960x540.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-07 11:52:162026-01-07 13:32:03Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal
https://european-biotechnology.net/wp-content/uploads/2026/01/pawel-czerwinski-prMn9KINLtI-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-06 18:06:152026-01-06 18:06:15Amgen acquires Dark Blue Therapeutics for up to $840 million
https://european-biotechnology.net/wp-content/uploads/2026/01/pexels-savvas-stavrinos-270619-814544-1030x686-1.jpg6861030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-06 10:37:272026-01-06 10:37:27Servier and Insilico sign an $888 million AI oncology discovery deal
